Skip to main content
Equibles

Schonfeld Strategic Advisors LLC

Position in GMAB — Genmab A/S

CIK 1665241 NEW YORK, NY
Back to GMAB Full portfolio

Position in GMAB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,882,966
+$3,521,647 QoQ
Shares Held
141,353
+949.6% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#50
of 292 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. GMAB ranks #29 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INBX
Inhibrx Biosciences, Inc.
 697,586 $66,096,273
2 AGIO
Agios Pharmaceuticals, Inc.
 520,083 $19,300,280
3 JAZZ
Jazz Pharmaceuticals plc
 77,272 $18,620,233
4 VRDN
Viridian Therapeutics, Inc.\DE
 793,508 $14,576,741
5 MBX
MBX Biosciences, Inc.
 248,670 $13,726,584
6 XENE
Xenon Pharmaceuticals Inc.
 227,330 $13,721,638
7 PTCT
Ptc Therapeutics, Inc.
 147,425 $12,025,457
8 INSM
INSMED Inc
 104,378 $11,128,782

All Filings in GMAB

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,882,966 141,353
2026-03-31 $361,319 13,467
2025-03-31 $207,332 10,589
2023-09-30 $7,999,306 226,802
2022-09-30 $7,930,583 246,828
2022-06-30 $6,846,877 210,738
2022-03-31 $3,368,719 93,110
2021-12-31 $3,575,076 90,371
2021-09-30 $5,745,195 131,469
2021-06-30 $3,284,773 80,450
2021-03-31 $4,945,281 150,633
2020-12-31 $3,527,620 86,759
2020-09-30 $3,213,186 87,768
2020-06-30 $1,408,298 41,555
2020-03-31 $748,176 35,308